GHK-CU Quotation Checklist — this article examines published research context, laboratory applications, and procurement notes for GHK-CU (50mg / 100mg) in Skin & Cosmetic Research programs at Sulan Peptide Official.
GHK-CU, also known as Copper Tripeptide-1, is a copper-binding tripeptide complex used in laboratory research on extracellular-matrix signaling, fibroblast models, copper-peptide coordination, and skin-biology research systems.
Sulan Peptide places GHK-CU in the Skin & Cosmetic Research category because research buyers often review it alongside extracellular-matrix, fibroblast, copper coordination, and cosmetic peptide formulation studies.
The GHK-CU page includes CAS number, formula, molecular weight, appearance, storage, and available 50mg and 100mg specification options to support research-use sourcing decisions.
Cosmetic peptide formulation researchers
Laboratories preparing GHK-CU protocols commonly pair the material with Sterile research diluent, Precision laboratory pipettes, Low-bind microtubes, Vial storage organizers (-20°C). These are workflow accessories—not bundled in the vial.
Research teams working with GHK-CU often include Skin-biology research labs, Extracellular-matrix research teams, Fibroblast model researchers, Cosmetic peptide formulation researchers, Qualified peptide procurement teams. These groups typically require documented peptide identity, batch COA review, and RUO compliance before releasing material into cell or animal protocols.
GHK-Cu binds copper(II) to form a tripeptide complex studied for extracellular matrix gene regulation (collagen, elastin, glycosaminoglycan synthesis) in dermal fibroblast cultures.
Research measures lysyl oxidase activity and TGF-β pathway transcripts when fibroblasts are treated with copper-peptide complexes at defined concentrations.
Scratch wound closure, procollagen type I ELISA, and copper uptake assays by ICP-MS support mechanism studies in cosmetic research laboratories.
Loren Pickart’s work established GHK as a plasma peptide fragment with matrix remodeling signatures in gene-expression microarray datasets.
Quotation preparation: Example subject — Quote request: GHK-CU (50mg / 100mg) | Qty [X] | Destination [Country]. Attach the product URL from sulanpeptide.shop and list required COA or Janoshik documentation.
Available GHK-CU research formats on sulanpeptide.shop include 50mg10vials, 100mg10vials. Cat No. references (CU50, CU100) should appear on requisitions so quoted material matches the specification selected during protocol design.
Multi-line quotes including GHK-CU are easier to confirm when Cat No. and specification appear in a table format with RUO acknowledgment and shipping preferences in the same message.
When GHK-CU appears in combination with other peptides, cite each sequence’s Cat No. in publications to satisfy reproducibility standards in Skin & Cosmetic Research journals.
Statistical plans should pre-register primary endpoints before unblinding GHK-CU treatment arms in preclinical models.
Shipping seasonality can affect lyophilized cake integrity for GHK-CU; inspect vials after extreme transit delays even if COA predates shipment.
Training records for staff handling GHK-CU should cover reconstitution math, RUO policy, and spill cleanup for research laboratories.
Dose–response studies with GHK-CU typically span log-scale concentrations; your protocol should state whether dosing is by mass (50mg / 100mg) or molarity derived from molecular weight on the product page.
Published Skin & Cosmetic Research papers often include positive and negative assay controls alongside GHK-CU; budget control compounds before ordering experimental material.
When designing multi-arm studies, randomize vial lot assignment and blind analysts to supplier identity until primary readouts are locked—this reduces bias in vendor comparison experiments involving GHK-CU.
Literature searches for GHK-CU should use both trade names and CAS 89030-95-5 to capture mechanistic papers missed by supplier marketing keywords alone.
Catalog specification data for GHK-CU lists CAS 89030-95-5, Molecular formula C14H23CuN6O4+. molecular weight 402.92 g/mol, and purity target ≥ 99.0%. Match these identifiers to incoming COA documents and internal sample labels before assay use.
Supplier storage guidance for GHK-CU: Store at -20°C, in a cool and dry place. Log receipt date, lot number, and freezer location when material enters your inventory. Plan aliquots before reconstitution to limit freeze-thaw cycles during multi-week assay series.
For long-horizon Skin & Cosmetic Research projects, document freezer location and thaw count on every aliquot label tied to GHK-CU lot numbers.
Appearance notes (Blue Lyophilized Powder) help detect moisture exposure or handling damage during receiving inspection of GHK-CU.
Internal IRB or IACUC protocols should cite RUO scope explicitly when GHK-CU appears in animal or human-derived tissue research models.
Compare published assay incubation times for GHK-CU; overnight versus short pulses can invert apparent potency rankings in receptor assays.
Purity target ≥ 99.0% on the catalog is a specification goal—your QA team should confirm the specific lot COA meets internal thresholds before release.
Pilot experiments with GHK-CU often start at mid-range catalog specifications (50mg / 100mg) before scaling quantity for full study cohorts.
Cell viability panels should precede mechanism assays when introducing GHK-CU to new cell lines—unexpected toxicity may reflect solvent choice rather than peptide sequence.
GHK-CU from Sulan Peptide Official is supplied for research use only (RUO)—not for human or veterinary use, diagnosis, or treatment. Direct specification or quotation questions via the Contact page or WhatsApp on sulanpeptide.shop.